These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31790893)

  • 21. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.
    Wang F; Wang Q; Zhou ZW; Yu SN; Pan ST; He ZX; Zhang X; Wang D; Yang YX; Yang T; Sun T; Li M; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():537-60. PubMed ID: 25632222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels.
    Reinicke KE; Bey EA; Bentle MS; Pink JJ; Ingalls ST; Hoppel CL; Misico RI; Arzac GM; Burton G; Bornmann WG; Sutton D; Gao J; Boothman DA
    Clin Cancer Res; 2005 Apr; 11(8):3055-64. PubMed ID: 15837761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.
    De U; Son JY; Jeon Y; Ha SY; Park YJ; Yoon S; Ha KT; Choi WS; Lee BM; Kim IS; Kwak JH; Kim HS
    Food Chem Toxicol; 2019 Jan; 123():492-500. PubMed ID: 30458268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth.
    Zhan S; Lu L; Pan SS; Wei XQ; Miao RR; Liu XH; Xue M; Lin XK; Xu HL
    Br J Cancer; 2022 Jul; 127(2):364-376. PubMed ID: 35396498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer.
    Manmuan S; Sakunrangsit N; Ketchart W
    Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1042-1052. PubMed ID: 28656701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone.
    Tsao YC; Chang YJ; Wang CH; Chen L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
    Hiscox S; Baruha B; Smith C; Bellerby R; Goddard L; Jordan N; Poghosyan Z; Nicholson RI; Barrett-Lee P; Gee J
    BMC Cancer; 2012 Oct; 12():458. PubMed ID: 23039365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
    Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
    Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
    Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
    Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.
    Wu C; Luo J
    Med Sci Monit; 2016 Oct; 22():3860-3867. PubMed ID: 27765938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation.
    Lee JH; Yeon JH; Kim H; Roh W; Chae J; Park HO; Kim DM
    PLoS One; 2012; 7(9):e45023. PubMed ID: 23028742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NADPH quinone oxidoreductase 1 mediates breast cancer cell resistance to thymoquinone-induced apoptosis.
    Sutton KM; Doucette CD; Hoskin DW
    Biochem Biophys Res Commun; 2012 Sep; 426(3):421-6. PubMed ID: 22960073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cisplatin-induced nephrotoxicity.
    Gang GT; Kim YH; Noh JR; Kim KS; Jung JY; Shong M; Hwang JH; Lee CH
    Toxicol Lett; 2013 Aug; 221(3):165-75. PubMed ID: 23831944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells.
    Calahorra J; Blaya-Cánovas JL; Castellini-Pérez O; Aparicio-Puerta E; Cives-Losada C; Marin JJG; Rementeria M; Cara FE; López-Tejada A; Griñán-Lisón C; Aulicino F; Berger I; Marchal JA; Delgado-Almenta V; Granados-Principal S
    Biomed Pharmacother; 2024 May; 174():116439. PubMed ID: 38518601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
    Hwang GH; Ryu JM; Jeon YJ; Choi J; Han HJ; Lee YM; Lee S; Bae JS; Jung JW; Chang W; Kim LK; Jee JG; Lee MY
    Eur J Pharmacol; 2015 Oct; 765():384-93. PubMed ID: 26341012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers.
    Yang Y; Zhou X; Xu M; Piao J; Zhang Y; Lin Z; Chen L
    Sci Rep; 2017 Jun; 7(1):2681. PubMed ID: 28578385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plumbagin promotes mitochondrial mediated apoptosis in gefitinib sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation.
    Panda M; Tripathi SK; Biswal BK
    Mol Biol Rep; 2020 Jun; 47(6):4155-4168. PubMed ID: 32444975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
    Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
    Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8
    Jiang ZB; Xu C; Wang W; Zhang YZ; Huang JM; Xie YJ; Wang QQ; Fan XX; Yao XJ; Xie C; Wang XR; Yan PY; Ma YP; Wu QB; Leung EL
    Pharmacol Res; 2021 Jul; 169():105656. PubMed ID: 33964470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.